Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Vortioxetine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A known ✓ | P08908 | 20/20 | 0.95 |
| ▸ | HTR3A known ✓ | P46098 | 20/20 | 0.95 |
| ▸ | SLC6A4 known ✓ | P31645 | 2/20 | 0.95 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.95 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.95 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.95 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.95 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.95 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.95 |
| ▸ | HRH2 | P25021 | 2/20 | 0.95 |
| ▸ | HTR1B | P28222 | 2/20 | 0.95 |
| ▸ | HTR2A | P28223 | 2/20 | 0.95 |
| ▸ | HTR2C | P28335 | 2/20 | 0.95 |
| ▸ | HTR7 | P34969 | 2/20 | 0.95 |
| ▸ | HRH1 | P35367 | 2/20 | 0.95 |
| ▸ | HTR5A | P47898 | 2/20 | 0.95 |
| ▸ | HTR6 | P50406 | 2/20 | 0.95 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.95 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.95 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vortioxetine SCHEMBL30153367 | 1.00 | HTR1A (0.95) | HTR1AHTR3ACYP1A2CYP3A4CYP2D6 | |
| Vortioxetine SCHEMBL29734869 | 1.00 | HTR1A (0.95) | HTR1AHTR3ACYP1A2CYP3A4CYP2D6 | |
| Vortioxetine SCHEMBL29393393 | 0.99 | HTR1A (0.97) | HTR1AHTR3ACYP1A2CYP3A4CYP2D6 | |
| Vortioxetine SCHEMBL19717678 | 0.99 | HTR1A (0.97) | HTR1AHTR3ACYP1A2CYP3A4CYP2D6 | |
| Vortioxetine SCHEMBL237653 | 0.99 | HTR1A (0.97) | HTR1AHTR3ACYP1A2CYP3A4CYP2D6 | |
| Vortioxetine SCHEMBL29469584 | 0.97 | HTR1A (1.00) | HTR1AHTR3ACYP1A2CYP3A4CYP2D6 | |
| Vortioxetine SCHEMBL236115 | 0.97 | HTR1A (1.00) | HTR1AHTR3ACYP1A2CYP3A4CYP2D6 | |
| Vortioxetine SCHEMBL15623040 | 0.97 | HTR1A (1.00) | HTR1AHTR3ACYP1A2CYP3A4CYP2D6 | |
| Vortioxetine SCHEMBL18687167 | 0.96 | HTR1A (0.97) | HTR1AHTR3ACYP1A2CYP3A4CYP2D6 | |
| SCHEMBL28470746 | 0.96 | HTR1A (0.97) | HTR1AHTR3ACYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105254590-A | New crystal form of vortioxetine hydrobromide, preparation method and uses thereof | JIANGSU HANSOH PHARMACEUTICAL | 2016-01-20 | — | — | CN | disclosed |